Related Experiment Video
Updated: May 21, 2025

MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease
Published on: February 14, 2012
Conversion between NMSS and MDS-NMS in Parkinson's Disease
Michela Garon1,2, José-Manuel Rojo-Albuin3, K Ray Chaudhuri4,5
1Padua Neuroscience Center (PNC), University of Padua, Padua, Italy.
Background:
The burden of non-motor symptoms in Parkinson's disease (PD) can be measured with the Non-Motor Symptoms Scale (NMSS) and the International Parkinson and Movement Disorder Society Non-Motor Rating Scale (MDS-NMS), for which scoring systems, structure and clinical coverage differ.
Objectives:
The goal was to develop conversion formulas between the NMSS and the MDS-NMS scores.
Methods:
Data from 402 patients with PD participating in the primary MDS-NMS validation study were used. The association between domain and total scores of both scales was assessed by the Spearman rank correlation coefficient and Kendall's W concordance coefficient. Equations for between-scale transformation of total score were constructed from weighted linear regression models.
Results:
Spearman rank correlations showed that MDS-NMS domains correlated 0.39 to 0.88 with the corresponding NMSS domains. The equation for transforming the NMSS total score to MDS-NMS total score is: MDS-NMS = 11.629 + 1.624 × NMSS (P < 0.001, R2 = 0.748). For converting the MDS-NMS total score to NMSS total score, the formula is NMSS = 2.475 + 0.495 × MDS-NMS (P < 0.001, R2 = 0.771).
Conclusions:
Our conversion equations enable direct comparison of the NMSS and MDS-NMS instruments, facilitating data comparability across studies. © 2025 International Parkinson and Movement Disorder Society.
Related Concept Videos
Parkinson's Disease: Overview
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Neural Regulation

